Targeting intestinal cancer stem cells for cancer therapy: Anticancer drug Epirubicin inhibits Achaete scute-like 2 (Ascl2) expression via up regulation of its target gene, 29/October/2013, 6.34 am

Therapetic targeting of Glucose pathways: Anticancer drug Epirubicin inhibits Glucose phosphate isomerase expression via up regulation of its target gene, 29/October/2013, 6.26 am
November 29, 2013
Anticancer drug Epirubicin inhibits Cyclin D2 expression via up regulation of its target gene, 29/October/2013, 6.48 am
November 29, 2013

Idea Proposed byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, Targeting intestinal cancer stem cells for cancer therapy: Anticancer drug Epirubicin inhibits Achaete scute-like 2 (Ascl2)  expression  via up regulation of its target gene, 29/October/2013, 6.34 am,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Comments are closed.